the Relationship Between Helicobacter Pylori Infection and Irritable Bowel Syndrome
NCT04847401 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80
Last updated 2021-04-19
Summary
Evaluating any possible relationship between irritable bowel syndrome occurrence and Helicobacter pylori infection
Conditions
- Irritable Bowel Syndrome
Interventions
- DIAGNOSTIC_TEST
-
H. pylori stool antigen
using H. pylori antigen kits in stool
Sponsors & Collaborators
-
Sohag University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-05-25
- Primary Completion
- 2021-11-01
- Completion
- 2022-01-01
More Related Trials
-
Predictive Factors for a Clinical Diagnosis of Irritable Bowel Syndrome in a Large Cohort of Young Adults.
NCT01854060 ·Status: COMPLETED
-
Efficacy of a Probiotic Blend to Reduce Gastrointestinal Symptoms in Patients With Irritable Bowel Syndrome
NCT05819281 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparison of the Effects of Different Nutrition Treatments on Patients With Irritable Bowel Syndrome
NCT04853381 ·Status: COMPLETED ·Phase: NA
-
The Prevalence and Risk Factors of Irritable Bowel Syndrome Among Adults
NCT05340400 ·Status: COMPLETED
-
Fecal Metabolome and the Intestinal Microbiota in Irritable Bowel Syndrome
NCT02981888 ·Status: COMPLETED
-
Investigating the Gut Microbiome and Symptomology in IBS
NCT06708533 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Stool Microbiome of Treated and Untreated IBS (Irritable Bowel Syndrome) Patients
NCT05972317 ·Status: RECRUITING ·Phase: NA
-
Analysis of Differences in Small Intestinal Microbiota Structure and Metabolites Between Patients With Irritable Bowel Syndrome and Healthy Individuals
NCT07212569 ·Status: NOT_YET_RECRUITING
-
Evaluation of Treatment Effect of Low FODMAP Diet in Treatment of IBS Patients
NCT05144204 ·Status: UNKNOWN ·Phase: NA
-
Intestinal Microbiome and Psychological Correlates in Irritable Bowel Syndrome and Inflammatory Bowel Disease
NCT02536131 ·Status: COMPLETED ·Phase: NA
-
The Expression of the Ionotropic Glutamate Receptors in Colon of IBS
NCT02512146 ·Status: UNKNOWN
-
Small Intestinal Bacterial Overgrowth: A Prospective Registry
NCT01822470 ·Status: ENROLLING_BY_INVITATION
-
Multicenter Observational Prospective Study to Describe Irritable Bowel Syndrome in the Russian Federation
NCT03549143 ·Status: COMPLETED
-
Exercise and Irritable Bowel Syndrome (IBS)
NCT05453084 ·Status: COMPLETED ·Phase: NA
-
The Long Term Clinical Course of Postinfectious Irritable Bowel Syndrome After Shigellosis; A 10 Year Follow up Study
NCT02516683 ·Status: COMPLETED
-
Understanding Abdominal Pain in IBD and IBS
NCT04020835 ·Status: UNKNOWN
-
Comorbid Esophageal Disorders in IBS Patients
NCT04759378 ·Status: UNKNOWN ·Phase: NA
-
Effects of Continuous Treatment With Rifaximin and Probiotics on the Gut Microbiota of Patients With IBS-D
NCT04074421 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of Probiotics in IBS Subjects
NCT03482765 ·Status: COMPLETED ·Phase: NA
-
SIBO, Immune Activation, and FGIDs in Children
NCT02872961 ·Status: COMPLETED
-
Role of Parasitic Infection in Inflammatory Bowel Disease and Irritable Bowel Syndrome
NCT04760600 ·Status: UNKNOWN
-
Efficacy/Safety Study to Confirm Iberogast's Efficacy in Patients With Irritable Bowel Syndrome Diagnosed on ROME III Criteria Compared to Placebo
NCT01940848 ·Status: COMPLETED ·Phase: PHASE3
-
Lactulose and Glucose Breath Tests as Predictors of Clinical Benefit From Rifaximin in Irritable Bowel Syndrome
NCT01803724 ·Status: UNKNOWN
-
Gut Permeability, Sensitivity and Symptomatology
NCT02358564 ·Status: COMPLETED ·Phase: NA
-
Incidence and Predictive Factor of Irritable Bowel Syndrome After Acute Diverticulitis in Korea
NCT02003807 ·Status: COMPLETED